Anti-CGRP monoclonal antibodies improve cognitive function in patients affected by chronic migraine complicated with medication overuse-headache

Journal article

Simona Guerzoni, Flavia Lo Castro, Carlo Baraldi, Daria Brovia, Fabio Tascedda, Veronica Rivi and Luca Pani

Confinia Cephalalgica et Neurologica, Vol.34(1), 15760

2024-05-07

Abstract

calcitonin gene-related peptide

erenumab

fremanezumab

galcanezumab

Montreal Cognitive Assessment

url

https://doi.org/10.4081/cc.2024.15760View

Published (Version of record) Open

1 Record Views

Title: Anti-CGRP monoclonal antibodies improve cognitive function in patients affected by chronic migraine complicated with medication overuse-headache
Creators: Simona Guerzoni - Polyclinic Medical Center
Flavia Lo Castro - Polyclinic Medical Center
Carlo Baraldi - Polyclinic Medical Center
Daria Brovia - Polyclinic Medical Center
Fabio Tascedda - University of Modena and Reggio Emilia
Veronica Rivi - University of Modena and Reggio Emilia
Luca Pani - University of Modena and Reggio Emilia
Publication Details: Confinia Cephalalgica et Neurologica, Vol.34(1), 15760
Academic Unit: Miller School of Medicine; UMMG Dept of Psychiatry & Behavioral Sciences
Language: English
Resource Type: Journal article
Record Identifier: 991032796338602976